|
Lax A, Soler F, Fernandez Del Palacio MJ, Pascual-Oliver S, Ballester MR, Fuster JJ, Pascual-Figal D, Asensio-Lopez MDC. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55alpha/YY1/sST2 signaling axis. Mol Ther Nucleic Acids. 2023 May 3;32:704-720. doi: 10.1016/j.omtn.2023.04.031. eCollection 2023 Jun 13. PubMed PMID: 37234747; PubMed Central PMCID: PMC10208836.
AÑO: 2023; IF: 6.1
|
|
Lax A., Soler F., Fernandez del Palacio M.J., Pascual-Oliver S., Ballester M.R., Fuster J.J., Pascual-Figal D., Asensio-Lopez M.d.C. Silencing of microRNA-106b-5p prevents doxorubicin-mediated cardiotoxicity through modulation of the PR55α/YY1/sST2 signaling axis. Molecular Therapy Nucleic Acids. 13 June 2023. 32:704-720. 10.1016/j.omtn.2023.04.031
AÑO: 2023; IF: 6.5
|
|
Sanchez-Camara S, Asensio-Lopez MC, Royo-Villanova M, Soler F, Jara-Rubio R, Garrido-Penalver JF, Pinar E, Hernandez-Vicente A, Hurtado JA, Lax A, Pascual-Figal DA. Critical warm ischemia time point for cardiac donation after circulatory death. Am J Transplant. 2022 May;22(5):1321-1328. doi: 10.1111/ajt.16987. Epub 2022 Feb 21. PubMed PMID: 35114047; PubMed Central PMCID: PMC9303247.
AÑO: 2022; IF: 8.8
|
|
Roncalli J., Tronchère H., Lax A., Kunduzova O. Editorial: Myocardial Remodeling: Mechanisms and Translational Implications. Frontiers in Pharmacology. 26 May 2022. 13. 10.3389/fphar.2022.930387
AÑO: 2022; IF: 5.6
|
|
Asensio-Lopez MC, Sassi Y, Soler F, Fernandez Del Palacio MJ, Pascual-Figal D, Lax A. The miRNA199a/SIRT1/P300/Yy1/sST2 signaling axis regulates adverse cardiac remodeling following MI. Sci Rep. 2021 Feb 16;11(1):3915. doi: 10.1038/s41598-021-82745-9. PubMed PMID: 33594087; PubMed Central PMCID: PMC7887255.
AÑO: 2021; IF: 4.996
|